Published in Hepatology on June 01, 2010
The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation. J Hepatol (2010) 1.69
The bile acid membrane receptor TGR5: a valuable metabolic target. Dig Dis (2011) 0.99
Endothelial nitric oxide synthase is a key mediator of hepatocyte proliferation in response to partial hepatectomy in mice. Hepatology (2011) 0.96
Bile acids regulate cardiovascular function. Clin Transl Sci (2011) 0.95
Molecular adsorbent recirculating system and single-pass albumin dialysis in liver failure - a prospective, randomised crossover study. Crit Care (2016) 0.88
Cardiac structural and functional alterations in infants and children with biliary atresia, listed for liver transplantation. Gastroenterology (2011) 0.87
Impaired bile acid handling and aggravated liver injury in mice expressing a hepatocyte-specific RXRα variant lacking the DNA-binding domain. J Hepatol (2013) 0.86
Not all (bile acids) who wander are lost: the first report of a patient with an isolated NTCP defect. Hepatology (2014) 0.79
Bile acids induce arrhythmias: old metabolite, new tricks. Heart (2013) 0.76
Bile acid excess induces cardiomyopathy and metabolic dysfunctions in the heart. Hepatology (2016) 0.75
The impact of left ventricular hypertrophy on survival in candidates for liver transplantation. Liver Transpl (2014) 0.75
Cardiomyopathy reverses with recovery of liver injury, cholestasis and cholanemia in mouse model of biliary fibrosis. Liver Int (2014) 0.75
Renal Impairment with Sublethal Tubular Cell Injury in a Chronic Liver Disease Mouse Model. PLoS One (2016) 0.75
A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell (1998) 13.56
Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol (2006) 10.71
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature (2006) 9.36
A G protein-coupled receptor responsive to bile acids. J Biol Chem (2003) 4.76
Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell (2006) 4.64
Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci U S A (2002) 3.18
Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev (2006) 2.96
Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Res (2006) 2.95
Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes. Circ Res (1999) 2.37
Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development. Circ Res (2002) 2.32
Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy. Circulation (2003) 2.28
AMP-activated protein kinase in the heart: role during health and disease. Circ Res (2007) 2.27
Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes. J Biol Chem (2001) 1.87
Akt signaling mediates postnatal heart growth in response to insulin and nutritional status. J Biol Chem (2002) 1.86
Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies. J Med Chem (2008) 1.85
A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. Am J Pathol (2007) 1.70
Nuclear targeting of Akt enhances ventricular function and myocyte contractility. Circ Res (2005) 1.62
Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy. J Cell Physiol (2008) 1.48
Impact of liver transplantation on rate-corrected QT interval and myocardial function in children with chronic liver disease*. Pediatr Transplant (2008) 1.48
Leptin activates cardiac fatty acid oxidation independent of changes in the AMP-activated protein kinase-acetyl-CoA carboxylase-malonyl-CoA axis. J Biol Chem (2002) 1.46
Bile acids and signal transduction: role in glucose homeostasis. Cell Signal (2008) 1.45
Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology (1997) 1.41
The cardiac response to exercise in cirrhosis. Gut (2001) 1.37
Endotoxin leads to rapid subcellular re-localization of hepatic RXRalpha: A novel mechanism for reduced hepatic gene expression in inflammation. Nucl Recept (2004) 1.30
Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failure. Physiol Genomics (2006) 1.23
Cirrhotic cardiomyopathy. Semin Liver Dis (2008) 1.21
Therapy insight: Cirrhotic cardiomyopathy. Nat Clin Pract Gastroenterol Hepatol (2006) 1.19
Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites. Gut (2010) 1.15
Role of heme oxygenase-carbon monoxide pathway in pathogenesis of cirrhotic cardiomyopathy in the rat. Am J Physiol Gastrointest Liver Physiol (2001) 1.15
Switching metabolic genes to build a better heart. Circulation (2002) 1.13
Role of altered beta-adrenoceptor signal transduction in the pathogenesis of cirrhotic cardiomyopathy in rats. Gastroenterology (1996) 1.10
Cardiac electrophysiological abnormalities in patients with cirrhosis. J Hepatol (2006) 1.08
Taurocholate induces changes in rat cardiomyocyte contraction and calcium dynamics. Clin Sci (Lond) (2002) 1.08
Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Gastroenterology (2000) 1.07
Reduced exercise endurance in interleukin-6-deficient mice. Endocrinology (2004) 1.07
Liver transplantation in children with glycogen storage disease: controversies and evaluation of the risk/benefit of this procedure. Pediatr Transplant (2008) 1.07
A study of heart disease in one hundred eight hospitalized patients dying with portal cirrhosis. AMA Arch Intern Med (1958) 1.06
Cardiac and systemic haemodynamic complications of liver cirrhosis. Scand Cardiovasc J (2009) 1.05
Alterations in energy metabolism in cardiomyopathies. Ann Med (2007) 1.04
Bile acid-induced Mallory body formation in drug-primed mouse liver. Am J Pathol (2002) 1.03
Circadian rhythms in myocardial metabolism and contractile function: influence of workload and oleate. Am J Physiol Heart Circ Physiol (2007) 1.02
Mitochondrial uncoupling protein 3 and its role in cardiac- and skeletal muscle metabolism. Physiol Behav (2007) 1.01
Glycogen in the heart--an expanded view. J Mol Cell Cardiol (2004) 1.01
Reversibility of PRKAG2 glycogen-storage cardiomyopathy and electrophysiological manifestations. Circulation (2007) 0.98
Analysis of impaired exercise capacity in patients with cirrhosis. Dig Dis Sci (1998) 0.95
RBCK1, a protein kinase CbetaI (PKCbetaI)-interacting protein, regulates PKCbeta-dependent function. J Biol Chem (2006) 0.92
The effects of bile acids on beta-adrenoceptors, fluidity, and the extent of lipid peroxidation in rat cardiac membranes. Biochem Pharmacol (2000) 0.90
Mitochondrial proteins in hypertrophy and atrophy: a transcript analysis in rat heart. Clin Exp Pharmacol Physiol (2002) 0.89
An abnormal gene expression of the beta-adrenergic system contributes to the pathogenesis of cardiomyopathy in cirrhotic rats. Hepatology (2008) 0.88
Adrenergic pathways and left ventricular remodeling. J Card Fail (2002) 0.84
Is the immediate reversal of diastolic dysfunction of cirrhotic cardiomyopathy after liver transplantation a sign of the metabolic etiology? Liver Transpl (2009) 0.84
Left ventricular hypertrophy in rats with biliary cirrhosis. Hepatology (2003) 0.82
Genes encoding bile acid, phospholipid and anion transporters are expressed in a human fetal cardiomyocyte culture. BJOG (2006) 0.80
CARDIAC HYPERTROPHY IN RATS WITH CARBON TETRACHLORIDE CIRRHOSIS. Arch Pathol (1965) 0.79
The emerging role of bile acids as integrators of intermediary metabolism. J Hepatol (2006) 0.77
Redundant pathways for negative feedback regulation of bile acid production. Dev Cell (2002) 3.51
An overview of second generation biofuel technologies. Bioresour Technol (2009) 2.95
Pattern of diagnostic evaluation for the causes of pediatric acute liver failure: an opportunity for quality improvement. J Pediatr (2009) 2.46
Demographically corrected norms for African Americans and Caucasians on the Hopkins Verbal Learning Test-Revised, Brief Visuospatial Memory Test-Revised, Stroop Color and Word Test, and Wisconsin Card Sorting Test 64-Card Version. J Clin Exp Neuropsychol (2011) 2.06
Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. AIDS (2011) 2.04
Recovery from chronic factitious disorder (Munchausen's syndrome): a personal account. Personal Ment Health (2013) 2.04
Effectiveness of first-line management strategies for stage I follicular lymphoma: analysis of the National LymphoCare Study. J Clin Oncol (2012) 1.99
Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era. J Neurovirol (2010) 1.95
Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort. AIDS (2011) 1.90
Extrahepatic anomalies in infants with biliary atresia: results of a large prospective North American multicenter study. Hepatology (2013) 1.80
Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease. Sci Transl Med (2013) 1.77
p53 rescue through HDM2 antagonism suppresses melanoma growth and potentiates MEK inhibition. J Invest Dermatol (2011) 1.77
Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. PLoS One (2012) 1.76
Patients with biliary atresia have elevated direct/conjugated bilirubin levels shortly after birth. Pediatrics (2011) 1.75
The natural history of hepatitis C virus in pediatric liver transplant recipients. Liver Transpl (2006) 1.61
Combined lung and liver transplantation: the United States experience. Transplantation (2005) 1.58
Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews. Cochrane Database Syst Rev (2014) 1.58
Epidermal growth factor-mediated activation of the ETS domain transcription factor Elk-1 requires nuclear calcium. J Biol Chem (2002) 1.53
Neonatal hemochromatosis: radiographical and histological signs. Liver Transpl (2005) 1.50
Analysis of recent pediatric orthotopic liver transplantation outcomes indicates that allograft type is no longer a predictor of survivals. Liver Transpl (2008) 1.46
Experimental determination of net protein charge, [A]tot, and Ka of nonvolatile buffers in bird plasma. J Appl Physiol (1985) (2006) 1.39
TOF-SIMS analysis of a 576 micropatterned copolymer array to reveal surface moieties that control wettability. Anal Chem (2007) 1.38
Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR. Pediatr Res (2007) 1.38
Extracellular ATP activates c-jun N-terminal kinase signaling and cell cycle progression in hepatocytes. Hepatology (2004) 1.35
Magnetic resonance derived myocardial strain assessment using feature tracking. J Vis Exp (2011) 1.32
Probiotic Lactobacillus reuteri promotes TNF-induced apoptosis in human myeloid leukemia-derived cells by modulation of NF-kappaB and MAPK signalling. Cell Microbiol (2008) 1.30
Quantification of accuracy and precision of multi-center DTI measurements: a diffusion phantom and human brain study. Neuroimage (2011) 1.30
Endotoxin leads to rapid subcellular re-localization of hepatic RXRalpha: A novel mechanism for reduced hepatic gene expression in inflammation. Nucl Recept (2004) 1.30
A mouse model of sitosterolemia: absence of Abcg8/sterolin-2 results in failure to secrete biliary cholesterol. BMC Med (2004) 1.28
HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS (2007) 1.25
Regulation of the lifespan in dendritic cell subsets. Mol Immunol (2007) 1.23
Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes. J Neurovirol (2010) 1.22
Conformational instability of the cholera toxin A1 polypeptide. J Mol Biol (2007) 1.22
Mechanisms underlying lack of insulin-like growth factor-binding protein-3 expression in non-small-cell lung cancer. Oncogene (2004) 1.21
Nuclear export of retinoid X receptor alpha in response to interleukin-1beta-mediated cell signaling: roles for JNK and SER260. J Biol Chem (2006) 1.21
Functional adaptation skills training (FAST): a pilot psychosocial intervention study in middle-aged and older patients with chronic psychotic disorders. Am J Geriatr Psychiatry (2003) 1.20
Coverage bias and sensitivity of variant calling for four whole-genome sequencing technologies. PLoS One (2013) 1.20
Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl (2013) 1.19
Treatment of children with chronic hepatitis B virus infection in the United States: patient selection and therapeutic options. Hepatology (2010) 1.19
Polymer surface functionalities that control human embryoid body cell adhesion revealed by high throughput surface characterization of combinatorial material microarrays. Biomaterials (2010) 1.18
Interleukin-1 beta-mediated suppression of RXR:RAR transactivation of the Ntcp promoter is JNK-dependent. J Biol Chem (2002) 1.16
Caspase-9-induced mitochondrial disruption through cleavage of anti-apoptotic BCL-2 family members. J Biol Chem (2007) 1.13
Split-liver transplantation using the left lateral segment: a collaborative sharing experience between two distant centers. Am J Transplant (2005) 1.09
The role of inflammation in cholestasis: clinical and basic aspects. Semin Liver Dis (2010) 1.07
Evaluation and management of patients with propionic acidemia undergoing liver transplantation: a comprehensive review. Pediatr Transplant (2006) 1.06
Kupffer cell depletion with liposomal clodronate prevents suppression of Ntcp expression in endotoxin-treated rats. J Hepatol (2005) 1.05
Early cardiac dysfunction in pediatric patients on maintenance dialysis and post kidney transplant. Pediatr Nephrol (2012) 1.05
Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy. J Pediatr Hematol Oncol (2010) 1.05
Intrahepatic cholestasis: summary of an American Association for the Study of Liver Diseases single-topic conference. Hepatology (2005) 1.04
Portal hypertension in children and young adults with biliary atresia. J Pediatr Gastroenterol Nutr (2012) 1.01
KARDIA: a Matlab software for the analysis of cardiac interbeat intervals. Comput Methods Programs Biomed (2009) 1.01
Risk stratification of adult patients undergoing orthotopic liver transplantation for fulminant hepatic failure. Transplantation (2006) 1.00
Efficacy of fat-soluble vitamin supplementation in infants with biliary atresia. Pediatrics (2012) 1.00
Stabilization of the tertiary structure of the cholera toxin A1 subunit inhibits toxin dislocation and cellular intoxication. J Mol Biol (2009) 0.99
Liver tumors: pediatric population. Liver Transpl (2008) 0.98
ATP release after partial hepatectomy regulates liver regeneration in the rat. J Hepatol (2009) 0.98
Do therapeutic bile acids hit the sweet spot of glucose metabolism in NAFLD? Gastroenterology (2013) 0.97
Treatment of neonatal hemochromatosis with exchange transfusion and intravenous immunoglobulin. J Pediatr (2009) 0.97
Preclinical evaluation of the metabolism and disposition of RRx-001, a novel investigative anticancer agent. Drug Metab Dispos (2012) 0.96
Endothelial nitric oxide synthase is a key mediator of hepatocyte proliferation in response to partial hepatectomy in mice. Hepatology (2011) 0.96
Recommendations for screening, monitoring, and referral of pediatric chronic hepatitis B. Pediatrics (2009) 0.95
Vemurafenib synergizes with nutlin-3 to deplete survivin and suppresses melanoma viability and tumor growth. Clin Cancer Res (2013) 0.95
DNA methyltransferase 1-associated protein (DMAP1) is a co-repressor that stimulates DNA methylation globally and locally at sites of double strand break repair. J Biol Chem (2010) 0.95
Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy. J Neurovirol (2013) 0.95
High throughput surface characterization: A review of a new tool for screening prospective biomedical material arrays. J Drug Target (2010) 0.94
Rapamycin (sirolimus) in tuberous sclerosis associated pediatric central nervous system tumors. Pediatr Blood Cancer (2010) 0.94
Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride. J Hepatol (2002) 0.94
Redundant roles for cJun-N-terminal kinase 1 and 2 in interleukin-1beta-mediated reduction and modification of murine hepatic nuclear retinoid X receptor alpha. J Hepatol (2009) 0.93
Contribution of subdomain structure to the thermal stability of the cholera toxin A1 subunit. Biochemistry (2010) 0.93
Regulation of hepatic drug-metabolizing enzyme genes by Toll-like receptor 4 signaling is independent of Toll-interleukin 1 receptor domain-containing adaptor protein. Drug Metab Dispos (2007) 0.92
Intestinal failure-associated liver disease: management and treatment strategies past, present, and future. Semin Liver Dis (2007) 0.91
Guideline for the Evaluation of Cholestatic Jaundice in Infants: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr (2017) 0.91
Blood donors' helping behavior is driven by warm glow: more evidence for the blood donor benevolence hypothesis. Transfusion (2012) 0.91
Effect of wrinkles on the surface area of graphene: toward the design of nanoelectronics. Nano Lett (2014) 0.91
Exact epidemic models on graphs using graph-automorphism driven lumping. J Math Biol (2010) 0.90
Children and television tipovers: a significant and preventable cause of long-term neurological deficits. J Neurosurg (2005) 0.89
Language and motor skills are impaired in infants with biliary atresia before transplantation. J Pediatr (2010) 0.89
Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies. J Neurovirol (2011) 0.88
Rosiglitazone attenuates suppression of RXRalpha-dependent gene expression in inflamed liver. J Hepatol (2006) 0.88
Lipid rafts alter the stability and activity of the cholera toxin A1 subunit. J Biol Chem (2012) 0.87
Coinfection with Staphylococcus aureus increases risk of severe coagulopathy in critically ill children with influenza A (H1N1) virus infection. Crit Care Med (2012) 0.87
Integrated approaches for the public health prioritization of foodborne and zoonotic pathogens. Risk Anal (2009) 0.87
Magnetic resonance spectroscopic studies of alcoholism: from heavy drinking to alcohol dependence and back again. Alcohol Clin Exp Res (2005) 0.87
Cardiac structural and functional alterations in infants and children with biliary atresia, listed for liver transplantation. Gastroenterology (2011) 0.87
Liver transplantation for severe hepatic graft-versus-host disease: an analysis of aggregate survival data. Liver Transpl (2005) 0.87
Progressive familial intrahepatic cholestasis type 3: overlapping presentation with Wilson disease. Clin Pediatr (Phila) (2012) 0.86
Orthotopic liver transplantation for biliary atresia: the U.S. experience. Liver Transpl (2005) 0.86
Structural and functional interactions between the cholera toxin A1 subunit and ERdj3/HEDJ, a chaperone of the endoplasmic reticulum. Infect Immun (2011) 0.86
Evaluation of asymmetric liposomal nanoparticles for encapsulation of polynucleotides. Langmuir (2008) 0.86
Avian bornavirus is present in many tissues of psittacine birds with histopathologic evidence of proventricular dilatation disease. J Vet Diagn Invest (2010) 0.86
Down-regulation of the Na+/taurocholate cotransporting polypeptide during pregnancy in the rat. J Hepatol (2003) 0.85
Treatment of acute tacrolimus whole-blood elevation with phenobarbital in the pediatric liver transplant recipient. Pediatr Transplant (2005) 0.84
Morphologic findings in progressive familial intrahepatic cholestasis 2 (PFIC2): correlation with genetic and immunohistochemical studies. Am J Surg Pathol (2011) 0.84